Title : FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657.

Pub. Date : 2010 Oct

PMID : 20435347






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657. SU 11657 KIT proto-oncogene, receptor tyrosine kinase Homo sapiens
2 FLT3 and KIT mutated samples were significantly more sensitive to SU11657 than WT KIT and FLT3 samples. SU 11657 KIT proto-oncogene, receptor tyrosine kinase Homo sapiens
3 Samples without KIT or FLT3 mutations, but with a high wild-type (WT) KIT expression were significantly more sensitive to SU11657 than samples with low KIT expression. SU 11657 KIT proto-oncogene, receptor tyrosine kinase Homo sapiens
4 Samples without KIT or FLT3 mutations, but with a high wild-type (WT) KIT expression were significantly more sensitive to SU11657 than samples with low KIT expression. SU 11657 KIT proto-oncogene, receptor tyrosine kinase Homo sapiens